IRW-Press: Bodybliss And Gemoscan Partner To Manage Food Sensitivity For Millions Of Filipinos



Published on 07 December 2012

Friendship Bands by Phoebe's Phashion ™Play The World's BIGGEST LOTTERY!

by Press Office

(IRW-PRESS and WireNews+Co)

Vienna, Austria


Bodybliss, the leading chain of Health and Wellness Centres serving the Filipino-Canadian community, announced a strategic partnership with Gemoscan Canada, Inc. (TSXV: GES; MUN: 1GE), to market the HEMOCODE™ Food Intolerance System. The HEMOCODE™ Food Intolerance System is a personalized naturopathic nutritional program that promotes dietary well-being and uses patented technology and services to provide consultation and recommendations to simplify the management of food sensitivities.

The 800,000-strong Filipino community in Canada represents the number one source of immigrants and contract workers for the country, making Tagalog, the Filipino language, Canada's fastest growing language. Fifty percent of Canada's Filipinos make the Greater Toronto Area their home.

Filipino Canadians will be able to identify and ask for HEMOCODE™ at Bodybliss as the Bodybliss-HEMOCODE™ Weight Management and Nutrition Program. The program, will include a comprehensive eight-week personalized exercise program, providing the Filipino-Canadian community with greater access to a wellness solution that is commonly understood to to impact weight imbalance, chronic pain, headaches, fatigue and more.

The Bodybliss-HEMOCODE™ Weight Management and Nutrition Program will be available in all seven Bodybliss Wellness Centres across the Greater Toronto Area beginning in December 2012.

'I am truly excited to launch the Bodybliss-HEMOCODE™ Weight Management and Nutritional Program. Food is a very important part of Filipino culture and with this programwe will be able to guide our customers toward making suitable food choices that can lead to better well-being by mitigating the potential onset of chronic symptoms and disease,' said Dr. Francis Rementilla, Chief Executive Officer of Bodybliss.

'Bodybliss and its founder, Dr. Rementilla, have been providing superb care for Toronto's rapidly growing Filipino community for over a decade. A strategic alliance with Bodybliss will help bring HEMOCODE™, our state-of-the art wellness program, to the Filipino community in Canada, while also providing us with a platform to reach millions of more consumers in the Philippines,' said Brian Kalish, Chief Executive Officer of Gemoscan Canada, Inc.

ABOUT BODYBLISS

For more than 12 years, Bodybliss has been caring for Canadian and Filipino-Canadian families with exceptional physiotherapy, orthopedic and wellness services. As part of its commitment to excellent care, time is taken to research and evaluate the latest technologies that enable the best possible patient care available. Bodybliss was founded and is led by Dr. Francis Rementilla, RPT, CPED (C), and is supported by a team of Registered Physiotherapists, Certified Pedorthists and healthcare clinicians

ABOUT THE HEMOCODE™ FOOD INTOLERANCE SYSTEM

The HEMOCODE™ Food Intolerance System is a personalized naturopathic nutritional program that promotes dietary well-being. It uses patented technology and services to provide consultation and recommendations to simplify the management of food sensitivities. The HEMOCODE™ Food Intolerance System is one of a growing number of wellness services and products offered by pharmacies as complementary medical choices. Complementary medicine is an adjunct to conventional medical practice, incorporating alternative modalities and therapies with a focus on lifestyle and wellness. A statistically significant base of practitioners and those using HEMOCODE™ report improved dietary wellness and satisfaction.

ABOUT GEMOSCAN CANADA, INC.

Gemoscan is an industry leader in food intolerance management and maintains a first-to- market position with Canada wide distribution through select retail partners. Founded in 2003, using its proprietary patented technology, Gemoscan develops, owns and markets comprehensive food sensitivity and dietary management solutions for consumers, including the HEMOCODE™ Food Intolerance System a personalized naturopathically supervised nutritional program that promotes well-being. Gemoscan is the first and only provider to commercialize a food intolerance management solution directly to consumers in partnership with retailers, and today offers the most comprehensive services available.

Gemoscan Canada, Inc. trades its shares on the Toronto Venture Exchange (TSX-V) under the symbol GES and is quoted on the Munich, Frankfurt and Stuttgart Stock Exchanges under the symbol 1GE.

Forward-Looking Information

This news release contains certain 'forward-looking information'. All statements, other than statements of historical fact that address activities, events or developments that Gemoscan believes, expects or anticipates will or may occur in the future. These forward-looking statements reflect the current expectations or beliefs of Gemoscan based on information currently available to Gemoscan. Forward-looking statements are subject to a number of significant risks and uncertainties and other factors that may cause the actual results of Gemoscan to differ materially from those discussed in the forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on Gemoscan. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, Gemoscan disclaims any intent or obligation to update any forward- looking statement, whether as a result of new information, future events or results or otherwise. Although Gemoscan believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information:

Bodybliss Corporation:
Dr. Francis Rementilla
Chief Executive Officer
416 224 9900
francis@bodybliss.ca

Gemoscan Canada:
Brian Kalish
Chief Executive Officer
Telephone: 416 650 1200
bkalish@hemocode.com

Media:
Leonard Zehr
Kilmer Lucas Inc.
T: (416) 833-9317
leonard@kilmerlucas.com


Contacts

  •  
  • Joachim Brunner
  • IRW-Press
  • PR Contact
  • Tel: +43724221193011
  •  
Enter your email:
Enter Subject:
Enter your message:
Please enter this numbers in the fields:
 
  Click image to get a new code.
Enter code:
 

Posted 2012-12-07 12:19:00